Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Lori A Leslie"'
Autor:
Ohad Benjamini, Shalev Fried, Roni Shouval, Jessica R. Flynn, Ofrat Beyar-Katz, Lori A Leslie, Tsilla Zucherman, Ronit Yerushalmi, Noga Shem-Tov, Maria Lia Palomba, Ivetta Danylesko, Inbal Sdayoor, Hila Malka, Orit Itzhaki, Hyung Suh, Sean M. Devlin, Ronit Marcus, Parastoo B Dahi, Elad Jacoby, Gunjan L Shah, Craig S Sauter, Andrew Ip, Miguel-Angel Perales, Arnon Nagler, Avichai Shimoni, Michael Scordo, Abraham Avigdor
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The activity of anti-CD19 CAR T cell therapy in chronic lymphocytic leukemia (CLL) with Richter's transformation (RT) to aggressive large B cell lymphoma (LBCL) is largely unknown. In a multicenter retrospective study, we report the safety and effica
Externí odkaz:
https://doaj.org/article/446c107a98b1415f962e7e3be018edfa
Autor:
Alexandra Della Pia, Gee Youn Geeny Kim, Andrew Ip, Jaeil Ahn, Yanzhi Liu, Simone Kats, Michael Koropsak, Brittany Lukasik, Anamta Contractor, Krushna Amin, Lakshmi Ayyagari, Charles Zhao, Amolika Gupta, Mark Batistick, Lori A Leslie, Andre H Goy, Tatyana A Feldman
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0266584 (2022)
Patients with hematologic malignancies have poor outcomes from COVID infection and are less likely to mount an antibody response after COVID infection. This is a retrospective study of adult lymphoma patients who received the COVID vaccine between 12
Externí odkaz:
https://doaj.org/article/1240adbd550e44a9bd3fe5a8137614d2
Autor:
Alessandra Petrillo, Andrew Ip, Alexandra Della Pia, Sarvainder Gill, Joshua Zenreich, Martin Gutierrez, Ann McNeill, Tatyana Feldman, Lori A. Leslie, Andre Goy
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e719 (2022)
Externí odkaz:
https://doaj.org/article/6222b57bd63f4f74b2b8562ba2b4a4eb
Autor:
Alexandra Della Pia, Charles Zhao, Parul Jandir, Amolika Gupta, Mark Batistick, Gee Youn (Geeny) Kim, Yi Xia, Jaeil Ahn, Gabriella Magarelli, Brittany Lukasik, Lori A. Leslie, Andre H. Goy, Andrew Ip, Tatyana A. Feldman
Publikováno v:
Cancers, Vol 14, Iss 17, p 4252 (2022)
Lymphoma patients are at greater risk of severe consequences from COVID-19 infection, yet most reports of COVID-19-associated outcomes were published before the advent of COVID-19 vaccinations and monoclonal antibodies (mAbs). In this retrospective s
Externí odkaz:
https://doaj.org/article/2a12e25c48f548fd857550918749e891
Autor:
Naomi H. Harley, Lori A. Leslie
Publikováno v:
Health Physics. 124:475-477
Autor:
Michael Scordo, Jessica R. Flynn, Sean M. Devlin, Mithat Gonen, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L. Porter, Stephen J. Schuster, Veronika Bachanova, Joseph E. Maakaron, Richard T. Maziarz, Loretta J. Nastoupil, Joseph P. McGuirk, Olalekan O. Oluwole, Andrew Ip, Lori A. Leslie, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Publikováno v:
Blood. 140:1588-1591
Autor:
Lindsey E. Roeker, Tatyana A. Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey, Andrew D. Zelenetz, Lorenzo Falchi, Jae H. Park, David J. Straus, Camila Pena Velasquez, Sonia Lebowitz, Yehudit Fox, Kristen Battiato, Carissa Laudati, Meghan C. Thompson, Elizabeth McCarthy, Sabrina Kdiry, Rosalba Martignetti, Teja Turpuseema, Michelle Purdom, Dana Paskalis, Hari P. Miskin, Peter Sportelli, Lori A. Leslie, Anthony R. Mato
Publikováno v:
Clinical Cancer Research. 28:3958-3964
Purpose: Ibrutinib has transformed the management of chronic lymphocytic leukemia (CLL), though its use is limited by toxicity and resistance. In this study, we utilized an “add on” approach for patients who had been treated with ibrutinib in the
Autor:
Anthony R. Mato, Lori A. Leslie, Peter Sportelli, Hari P. Miskin, Dana Paskalis, Michelle Purdom, Teja Turpuseema, Rosalba Martignetti, Sabrina Kdiry, Elizabeth McCarthy, Meghan C. Thompson, Carissa Laudati, Kristen Battiato, Yehudit Fox, Sonia Lebowitz, Camila Pena Velasquez, David J. Straus, Jae H. Park, Lorenzo Falchi, Andrew D. Zelenetz, Colleen Dorsey, Gail Panton, Victoria Falco, Jacob D. Soumerai, Tatyana A. Feldman, Lindsey E. Roeker
Supplementary Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c05b3ff2d51e9213b86e98036b3c6f
https://doi.org/10.1158/1078-0432.22487868
https://doi.org/10.1158/1078-0432.22487868
Autor:
Anthony R. Mato, Lori A. Leslie, Peter Sportelli, Hari P. Miskin, Dana Paskalis, Michelle Purdom, Teja Turpuseema, Rosalba Martignetti, Sabrina Kdiry, Elizabeth McCarthy, Meghan C. Thompson, Carissa Laudati, Kristen Battiato, Yehudit Fox, Sonia Lebowitz, Camila Pena Velasquez, David J. Straus, Jae H. Park, Lorenzo Falchi, Andrew D. Zelenetz, Colleen Dorsey, Gail Panton, Victoria Falco, Jacob D. Soumerai, Tatyana A. Feldman, Lindsey E. Roeker
Purpose:Ibrutinib has transformed the management of chronic lymphocytic leukemia (CLL), though its use is limited by toxicity and resistance. In this study, we utilized an “add on” approach for patients who had been treated with ibrutinib in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a26e24bc38e973d8f286db775058e90
https://doi.org/10.1158/1078-0432.c.6532596
https://doi.org/10.1158/1078-0432.c.6532596
Autor:
Lorenzo Falchi, Lori A. Leslie, David Belada, Katerina Kopeckova, Fritz Offner, Joshua Brody, Miguel Canales, Alejandro Martín García-Sancho, Marcel Nijland, P-O Andersson, Farrukh T. Awan, Jacob Haaber Christensen, Kristina Drott, Mats Hellström, Catharina Lewerin, Mayur Narkhede, Sylvia Snauwaert, Björn E Wahlin, Ali Rana, Aqeel Abbas, Liwei Wang, Minh Dinh, Joost S.P. Vermaat, Pau Abrisqueta
Publikováno v:
Blood. 140:1471-1473